Genmab A/S Announces Minor Capital Increase via Employee Warrant Exercise

On June 16, 2026, Genmab A/S announced a minor capital increase resulting from the exercise of employee warrants. The company issued 185 new ordinary shares at a price of DKK 1,334.50 per share. This transaction generated proceeds of approximately DKK 0.2 million for the company. The new shares represent less than 0.001% of Genmab's total share capital. These shares carry the same rights as existing ordinary shares, including dividend rights, and are expected to be listed on Nasdaq Copenhagen following registration with the Danish Business Authority. Following this increase, Genmab's total share capital consists of 62,353,252 shares, each with a nominal value of DKK 1, totaling a nominal value of DKK 62,353,252. This filing is a routine administrative update regarding the company's equity structure and does not impact clinical or commercial operations.